Impact of NO-synthase inhibition on renal hemodynamics in normotensive and hypertensive subjects

J Hypertens. 2002 Mar;20(3):525-30. doi: 10.1097/00004872-200203000-00029.

Abstract

Objective: To examine the acute effects of NO-synthase inhibition on renal hemodynamics in normotensive and hypertensive subjects.

Methods: Changes of renal plasma flow (RPF) and glomerular filtration rate (GFR) in response to intravenous infusions of NG-monomethyl-l-arginine (l-NMMA) (3 mg/kg per 30 min) were measured in 32 normotensive and in 39 essential hypertensive patients by use of clearance technique.

Results: l-NMMA significantly decreased RPF in normotensive and hypertensive individuals (P < 0.001), while GFR was preserved. Changes of renal hemodynamic parameters were similar in hypertensive and normotensive subjects (deltaRPF: -88 +/- 89 versus -81 +/- 105 ml/min, P = NS; deltaGFR 1.6 +/- 8.2 versus 4.3 +/- 8.9 ml/min, P = NS) Furthermore, l-NMMA increased mean arterial pressure (deltaMAP 5.3 +/- 6.3 versus 6.0 +/- 6.1 mmHg, P = NS) and decreased heart rate (deltaHR -5.8 +/- 3.9 versus -4.1 +/- 3.8 beats/min, P = NS) to a similar extent in both groups.

Conclusion: Basal NO synthesis of the renal vasculature is not impaired in patients with established essential hypertension.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Blood Pressure / drug effects
  • Cohort Studies
  • Enzyme Inhibitors / administration & dosage
  • Enzyme Inhibitors / pharmacology*
  • Female
  • Heart Rate / drug effects
  • Hemodynamics / drug effects
  • Humans
  • Hypertension / physiopathology*
  • Injections, Intravenous
  • Male
  • Middle Aged
  • Nitric Oxide Synthase / antagonists & inhibitors*
  • Reference Values
  • Renal Circulation / drug effects*
  • omega-N-Methylarginine / administration & dosage
  • omega-N-Methylarginine / pharmacology*

Substances

  • Enzyme Inhibitors
  • omega-N-Methylarginine
  • Nitric Oxide Synthase